HomeRNXT • NASDAQ
add
RenovoRx Inc
Previous close
$1.09
Day range
$1.06 - $1.14
Year range
$0.55 - $2.35
Market cap
26.15M USD
Avg Volume
24.60K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.03M | -10.10% |
Net income | -2.39M | -2.66% |
Net profit margin | — | — |
Earnings per share | -0.10 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 11.74M | 97.21% |
Total assets | 12.00M | 90.12% |
Total liabilities | 2.73M | -46.70% |
Total equity | 9.27M | — |
Shares outstanding | 23.99M | — |
Price to book | 2.79 | — |
Return on assets | -90.34% | — |
Return on capital | -137.42% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -2.39M | -2.66% |
Cash from operations | -2.30M | 17.11% |
Cash from investing | — | — |
Cash from financing | 9.65M | 92.92% |
Net change in cash | 7.35M | 229.58% |
Free cash flow | -1.30M | -37.37% |
About
Founded
2009
Headquarters
Website
Employees
10
